Based in Basel, Switzerland, Roche Holding AG is the owner of F. Hoffmann-La Roche Ltd., a provider of in-vitro diagnostics and drugs for cancer and transplantation. Traded on the SwissExchange, Active in over 100 countries and the largest biotech firm inthe work. Roche is working on medicines for oncology, virology, inflammation, metabolism, CNS, clinical chemistry, immunology, urinalysis, blood screening, genetics, infectious diseases, and microbiology. F. Hoffmann-La Roche Ltd. serves hospitals, research labs, private medical labs, practicing physicians, and patients. Specific products include cancer treatments, such as Avastin, Herceptin, and MabThera that are also effective in the treatment of rheumatoid arthritis, anemia, and osteoporosis. F. Hoffmann-La Roche Ltd., also conducts research and development as well as production related to molecular diagnostic reagents, test systems, and test kits. In addition, the firm provides automated instruments, software, consumables, and IT solutions used in in-vitro diagnostics and research.
